McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxOcGR6UUp2Q1I3OGZzMms2SjRGM3A5ZV84Z1J5SzhLOUF4eG9zblRWMjRGRHc3NWdOa28xOXlCS3FxTWRydHJxTjFqZUMxWVRkbnNENlpWbF82aVBBSlFydmgyVEFaQV94WlpXZlpuOW1JTWJZMTFldnR6bThpa2ZyMzBIaEVyeVVpdS1CYmlWZVRySC12UndlVHk3M05yM0tKY1otZHZ6VUdiWUl4WEcwY3RYdTZNeUxXdWVYNVUtNnVTSzM2M2hDYWZpZkhJdw?oc=5" target="_blank">McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Reuters
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports Reuters
October 5, 2026 at 09:09 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMBecton Dickinson pledges $19 billion US investment in deal with government - Reuters
Becton Dickinson pledges $19 billion US investment in deal with government Reuters
October 6, 2026 at 03:06 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMCanada's Weston family to buy UK's Boots in $8.9 billion deal - Reuters
Canada's Weston family to buy UK's Boots in $8.9 billion deal Reuters
October 7, 2026 at 04:53 PMEXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say - Reuters
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say Reuters
October 8, 2026 at 09:37 PM